Demande de produit
Asset Licensing Opportunity
Resources
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| LAE-102 | LAE-102 | Phase 2 Clinical | Solid tumours; Metabolic Dysfunction-Associated Steatotic Liver Disease; Carcinoma, Non-Small-Cell Lung | Details | |
| LAE-123 | LAE-123 | Details |
Customer Reviews